| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cathepsin K | 0.497 | 0.808 | 3.1E-05 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2005 | 2012 | ||||||||
|
WW and C2 domain containing 1 | 0.610 | 0.692 | 3.9E-04 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2013 | 2018 | ||||||||
|
sirtuin 5 | 0.610 | 0.615 | 8.7E-10 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2017 | 2019 | ||||||||
|
FUS RNA binding protein | 0.470 | 0.846 | 1.00 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2018 | 2019 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2013 | 2015 | ||||||||
|
delta like canonical Notch ligand 1 | 0.492 | 0.808 | 1.00 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2011 | 2012 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2006 | 2010 | ||||||||
|
inhibitor of growth family member 2 | 0.599 | 0.654 | 0.73 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2013 | 2015 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2008 | 2013 | ||||||||
|
microRNA 33a | 0.560 | 0.654 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2015 | 2019 | |||||||||
|
transmembrane 4 L six family member 1 | 0.644 | 0.462 | 1.6E-03 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2018 | 2018 | ||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1998 | 2017 | ||||||||
|
sirtuin 7 | 0.582 | 0.577 | 5.6E-04 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2015 | 2017 | ||||||||
|
sirtuin 6 | 0.496 | 0.846 | 3.9E-02 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2017 | 2017 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2013 | 2020 | ||||||||
|
frizzled class receptor 5 | 0.587 | 0.615 | 0.98 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2019 | 2019 | ||||||||
|
F-box protein 31 | 0.653 | 0.423 | 0.44 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2014 | 2018 | ||||||||
|
frizzled class receptor 1 | 0.587 | 0.615 | 4.2E-02 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2019 | 2019 | ||||||||
|
F2R like thrombin or trypsin receptor 3 | 0.539 | 0.769 | 4.1E-05 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2011 | 2015 | ||||||||
|
REC8 meiotic recombination protein | 0.729 | 0.231 | 5.5E-06 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2017 | 2018 | ||||||||
|
Rho GTPase activating protein 24 | 0.456 | 0.808 | 3.9E-10 |
|
disease | 0.050 | None | 0.600 | 5 | 0 | 2001 | 2015 | ||||||||
|
X-ray repair cross complementing 3 | 0.505 | 0.769 | 1.9E-10 |
|
disease | 0.400 | None | 0.636 | 11 | 2 | 2004 | 2017 | ||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
disease | 0.090 | None | 0.667 | 9 | 3 | 2001 | 2018 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.090 | None | 0.667 | 9 | 3 | 2005 | 2016 | ||||||||
|
mesothelin | 0.525 | 0.692 | 5.9E-25 |
|
disease | 0.320 | None | 0.667 | 3 | 0 | 2012 | 2019 |